Cargando…
Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture
BACKGROUND: In vitro expanded mesenchymal stromal cells (MSCs) are increasingly used as experimental cellular therapy. However, there have been concerns regarding the safety of their use, particularly with regard to possible oncogenic transformation. MSCs are the hypothesized precursor cells of high...
Autores principales: | Buddingh, Emilie P, Ruslan, S Eriaty N, Reijnders, Christianne M A, Szuhai, Karoly, Kuijjer, Marieke L, Roelofs, Helene, Hogendoorn, Pancras C W, Maarten Egeler, R, Cleton-Jansen, Anne-Marie, Lankester, Arjan C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477606/ https://www.ncbi.nlm.nih.gov/pubmed/26106474 http://dx.doi.org/10.1186/s13569-015-0031-1 |
Ejemplares similares
-
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells
por: Buddingh, Emilie P., et al.
Publicado: (2011) -
Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients
por: Buddingh, Emilie P., et al.
Publicado: (2012) -
Expression of the immune regulation antigen CD70 in osteosarcoma
por: Pahl, Jens HW, et al.
Publicado: (2015) -
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
por: Kuijjer, Marieke L, et al.
Publicado: (2014) -
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis
por: Berghuis, Dagmar, et al.
Publicado: (2012)